Cargando…
RANK, RANKL and osteoprotegerin in bone biology and disease
Upon the discovery of RANK, RANKL and OPG in the late 1990s, their importance in the maintenance of the skeletal structure and their dramatic role in bone disease were largely unexpected. In recent years the understanding of these proteins, in particular their regulation, has greatly increased. This...
Autores principales: | Wright, H. L., McCarthy, H. S., Middleton, J., Marshall, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684955/ https://www.ncbi.nlm.nih.gov/pubmed/19468919 http://dx.doi.org/10.1007/s12178-009-9046-7 |
Ejemplares similares
-
Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007) -
Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
por: Kohli, Sarvraj Singh, et al.
Publicado: (2011) -
NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
por: Irtyuga, Olga, et al.
Publicado: (2017) -
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021) -
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes
por: Kondegowda, Nagesha Guthalu, et al.
Publicado: (2023)